Načítá se...
Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
PURPOSE: To evaluate the efficacy and safety for mother and child of using intravenous iron isomaltoside (IV-IIM) during pregnancy. METHODS: Using an appointment register, we retrospectively identified all pregnant women who received a single dose of 1000 or 1500 mg IV-IIM in the maternity ward of F...
Uloženo v:
| Vydáno v: | Arch Gynecol Obstet |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7181549/ https://ncbi.nlm.nih.gov/pubmed/32270330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00404-020-05509-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|